Boston Private Wealth LLC Sells 790 Shares of Acadia Healthcare Company, Inc. (ACHC)
Boston Private Wealth LLC cut its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 85,759 shares of the company’s stock after selling 790 shares during the period. Boston Private Wealth LLC owned 0.10% of Acadia Healthcare worth $4,235,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. JPMorgan Chase & Co. raised its position in Acadia Healthcare by 0.8% in the first quarter. JPMorgan Chase & Co. now owns 7,705,975 shares of the company’s stock worth $335,980,000 after buying an additional 59,735 shares in the last quarter. Vanguard Group Inc. raised its position in Acadia Healthcare by 8.1% in the first quarter. Vanguard Group Inc. now owns 5,743,233 shares of the company’s stock worth $250,404,000 after buying an additional 431,550 shares in the last quarter. BlackRock Inc. raised its position in Acadia Healthcare by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after buying an additional 5,127,140 shares in the last quarter. Aristotle Capital Management LLC bought a new position in Acadia Healthcare during the first quarter worth $140,071,000. Finally, Frontier Capital Management Co. LLC raised its position in Acadia Healthcare by 11.5% in the second quarter. Frontier Capital Management Co. LLC now owns 2,328,063 shares of the company’s stock worth $114,960,000 after buying an additional 240,975 shares in the last quarter.
Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) opened at 47.13 on Monday. The firm has a 50-day moving average price of $50.51 and a 200-day moving average price of $45.06. The stock has a market capitalization of $4.14 billion, a P/E ratio of 517.91 and a beta of 1.15. Acadia Healthcare Company, Inc. has a 52-week low of $32.54 and a 52-week high of $54.34.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The company had revenue of $715.90 million during the quarter, compared to analysts’ expectations of $717.38 million. During the same quarter in the prior year, the company earned $0.73 EPS. Acadia Healthcare’s revenue was down 5.4% compared to the same quarter last year. On average, analysts predict that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “Boston Private Wealth LLC Sells 790 Shares of Acadia Healthcare Company, Inc. (ACHC)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2017/08/21/boston-private-wealth-llc-sells-790-shares-of-acadia-healthcare-company-inc-achc.html.
A number of research analysts have recently weighed in on ACHC shares. Jefferies Group LLC restated a “buy” rating on shares of Acadia Healthcare in a report on Monday, May 15th. BidaskClub lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday. Zacks Investment Research lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. William Blair started coverage on Acadia Healthcare in a report on Tuesday, July 18th. They set an “outperform” rating on the stock. Finally, Cantor Fitzgerald reiterated a “hold” rating and set a $45.00 price target on shares of Acadia Healthcare in a report on Wednesday, April 26th. One research analyst has rated the stock with a sell rating, four have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Acadia Healthcare currently has an average rating of “Buy” and an average price target of $59.21.
In other news, Director William Grieco sold 2,000 shares of the stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $45.42, for a total value of $90,840.00. Following the completion of the sale, the director now owns 47,013 shares of the company’s stock, valued at approximately $2,135,330.46. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Reeve B. Waud sold 50,000 shares of the stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $45.09, for a total transaction of $2,254,500.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,138,347 shares of company stock valued at $105,486,669. 11.10% of the stock is owned by corporate insiders.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).
Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.